Racked is no longer publishing. Thank you to everyone who read our work over the years. The archives will remain available here; for new stories, head over to Vox.com, where our staff is covering consumer culture for The Goods by Vox. You can also see what we’re up to by signing up here.
Damien Hirst no longer seems like the exception that proves the economic rule. Back in September, we were surprised and impressed when an auction of his work brought in $127.2 million—halfway before it ended. Now, though, it seems Hirst is laying off his staff: "On Thursday, up to 17 of the 22 people who make the pills for Hirst's drug cabinet series were told their contracts were not being renewed, according to two sources close to Science Ltd, Hirst's main art-producing company. Another three who make his butterfly paintings were also told they were surplus to requirements." [Guardian UK; Previously]